240 related articles for article (PubMed ID: 18262663)
21. [Glutamatergic mechanisms in alcohol dependence--genetic, molecular-biological and neuropharmacological findings].
Soyka M; Preuss U
Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S45-50. PubMed ID: 12947543
[TBL] [Abstract][Full Text] [Related]
22. Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
Egli M
Addict Biol; 2005 Dec; 10(4):309-19. PubMed ID: 16318951
[TBL] [Abstract][Full Text] [Related]
23. [A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Mutschler J; Grosshans M; Kiefer F
Neuropsychiatr; 2008; 22(4):283-5. PubMed ID: 19081000
[TBL] [Abstract][Full Text] [Related]
24. A translational approach to novel medication development for protracted abstinence.
Mason BJ; Higley AE
Curr Top Behav Neurosci; 2013; 13():647-70. PubMed ID: 22351425
[TBL] [Abstract][Full Text] [Related]
25. [General practitioner plays a central role as case manager. Diagnosis and therapy of alcoholism].
Soyka M
MMW Fortschr Med; 2003 Mar; 145(11):40-2. PubMed ID: 12688195
[TBL] [Abstract][Full Text] [Related]
26. [Biological basis of the screening of drugs for differentiated pharmacotherapy of alcoholism].
Val'dman AV; Maĭskiĭ AI; Kampov-Polevoĭ AB; Treskov VG; Drozdov ES
Vestn Akad Med Nauk SSSR; 1988; (3):28-32. PubMed ID: 3388968
[No Abstract] [Full Text] [Related]
27. Long-acting injectable naltrexone for the treatment of alcohol dependence.
Mannelli P; Peindl K; Masand PS; Patkar AA
Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
Haile CN; Kosten TA; Kosten TR
Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
[TBL] [Abstract][Full Text] [Related]
29. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
[TBL] [Abstract][Full Text] [Related]
30. Novel medication targets for the treatment of alcoholism: preclinical studies.
Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
[TBL] [Abstract][Full Text] [Related]
31. The contribution of genetics to addiction therapy approaches.
Edenberg HJ; Kranzler HR
Pharmacol Ther; 2005 Oct; 108(1):86-93. PubMed ID: 16026844
[TBL] [Abstract][Full Text] [Related]
32. The pharmacological treatment of alcoholism: from basic science to clinical medicine.
Verbanck PM
Alcohol Alcohol; 1995 Nov; 30(6):757-64. PubMed ID: 8679016
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological approach of the treatment of drinking problems: a critical overview.
Verbanck P; Barrias J; Besson J; Borg S
Alcohol Alcohol Suppl; 1993; 2():139-44. PubMed ID: 7748291
[TBL] [Abstract][Full Text] [Related]
34. The role of craving in alcohol use, dependence, and treatment.
Flannery BA; Roberts AJ; Cooney N; Swift RM; Anton RF; Rohsenow DJ
Alcohol Clin Exp Res; 2001 Feb; 25(2):299-308. PubMed ID: 11236847
[TBL] [Abstract][Full Text] [Related]
35. Baclofen: a new drug for the treatment of alcohol dependence.
Addolorato G; Leggio L; Agabio R; Colombo G; Gasbarrini G
Int J Clin Pract; 2006 Aug; 60(8):1003-8. PubMed ID: 16893442
[TBL] [Abstract][Full Text] [Related]
36. Serotonin and dopamine interactions in psychosis prevention.
Richtand NM; McNamara RK
Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
[TBL] [Abstract][Full Text] [Related]
37. The genetics of alcoholism.
Stacey D; Clarke TK; Schumann G
Curr Psychiatry Rep; 2009 Oct; 11(5):364-9. PubMed ID: 19785977
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy for Alcohol Use Disorder.
Holt SR; Tobin DG
Med Clin North Am; 2018 Jul; 102(4):653-666. PubMed ID: 29933821
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacology of disulfiram - an update].
Mutschler J; Diehl A; Kiefer F
Fortschr Neurol Psychiatr; 2008 Apr; 76(4):225-31. PubMed ID: 18415930
[TBL] [Abstract][Full Text] [Related]
40. [The effect of medikhronal on the psychophysiological and metabolic processes in alcoholism].
Kharchenko NK; Duplenko PIu; Kovtun TV; Stohniĭ NA; Synyts'kyĭ VM
Fiziol Zh (1994); 2000; 46(2):116-23. PubMed ID: 10867870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
